IRD
Opus Genetics
$3.35
+$0.27 (+8.77%)Jul 27, 2026
Key metrics
The numbers that frame IRD today
- Market cap
- $272.68M
- P/E (TTM)
- -2.5
- EV / FCF
- -5.5
- Gross margin
- 100%
- EV / Sales
- 17.8
- ROIC
- 1,046.2%
- Div yield
- 0%
- 52wk Low
- $1.04
- 52wk High
- $5.81
Growth
Revenue and earnings trend for IRD
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IRD
Is Opus Genetics a good buy?
Hold. Opus Genetics has excellent momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Opus Genetics is selling at a very high price.
What is the market capitalization of IRD?
Opus Genetics's market capitalization is $272.68M.
What is the P/E ratio for IRD stock?
Opus Genetics's current P/E ratio is -2.5.
What is the 52-week high for IRD stock?
The 52-week high for Opus Genetics is $5.81. The current close of $3.35 is 42.3% below that high.
What is the 52-week low for IRD stock?
The 52-week low for Opus Genetics is $1.04. The current close of $3.35 is 222.1% above that low.
Does IRD stock pay dividends?
Opus Genetics does not currently show a dividend per share in the company data.